Richard Mills to Clostridium Infections
This is a "connection" page, showing publications Richard Mills has written about Clostridium Infections.
Connection Strength
0.121
-
Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: A randomized Phase 2 clinical trial. Vaccine. 2016 Apr 27; 34(19):2170-8.
Score: 0.121